Clene

CLNN

CLNN Clene NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CLNN Chart
    See on advanced chart >

    About

    Clene Inc. was incorporated on November 13, 2017. Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the...
    • Highlight
      A clinical-stage biopharmaceutical company that develops nanotherapeutics for the treatment of neurodegenerative diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      08/27/2018
    • Established Date
      11/13/2017
    • Full-time Employees
      82
    • Address
      6550 South Millrock Drive Suite G50 Salt Lake City Utah
    • Tel
      1-801-6769695
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock